CLINICAL TRIALS PROFILE FOR BENAZEPRIL HYDROCHLORIDE

All Clinical Trials for BENAZEPRIL HYDROCHLORIDE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00136773 ↗	Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus	Completed	Novartis	Phase 4	2003-04-01	Type 2 diabetes mellitus is usually associated with high blood pressure, which is a risk factor for kidney disease. Aggressive blood pressure reduction is an important strategy to protect the kidney and reduce urinary protein which develops with kidney disease. This study will evaluate the effects of amlodipine/benazepril in reducing blood pressure and urinary protein in hypertensive subjects with type 2 diabetes mellitus.
NCT00136851 ↗	Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension	Completed	Novartis Pharmaceuticals	Phase 4	2004-12-01	This trial is designed to study the efficacy of an amlodipine besylate/benazepril treatment regimen versus an amlodipine treatment regimen in the treatment of severe hypertension.
NCT00139555 ↗	Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension	Completed	Novartis	Phase 4	2004-07-01	Left ventricular hypertrophy (LVH) increases the risk of cardiovascular morbidity and mortality in patients with high blood pressure, compared to those without LVH. Reduction of left ventricular mass (LVM) with antihypertensive agents is associated with improved clinical outcome. This study will evaluate the effects of amlodipine/benazepril in reducing LVM in patients with high risk hypertension.
NCT00170950 ↗	Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension	Terminated	Novartis	Phase 3	2003-10-01	A comparison study of two combination drugs, amlodipine/benazepril and benazepril/HCTZ to evaluate the effectiveness of the combination on reducing heart disease and death in a high risk hypertensive population.
NCT00171119 ↗	A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril	Terminated	Novartis Pharmaceuticals	Phase 4	2004-01-01	The purpose of this study is to evaluate the efficacy of valsartan, benazepril or the combination of both in reduction of microalbuminuria in Type 2 diabetic patients.
NCT00171366 ↗	A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.	Completed	Pfizer	Phase 3	2004-07-01	Comparison of the safety and efficacy of the combination of amlodipine/Benazepril to amlodipine monotherapy in patients with non-essential hypertension, not controlled on amlodipine alone.

Clinical Trial Conditions for BENAZEPRIL HYDROCHLORIDE

Condition Name

Condition Name for BENAZEPRIL HYDROCHLORIDE
Intervention	Trials
Hypertension	16
Healthy	11
Proteinuria	4
Diabetes	4

Condition MeSH

Condition MeSH for BENAZEPRIL HYDROCHLORIDE
Intervention	Trials
Hypertension	14
Diabetes Mellitus	6
Renal Insufficiency	4
Proteinuria	4

Clinical Trial Locations for BENAZEPRIL HYDROCHLORIDE

Trials by Country

Trials by Country for BENAZEPRIL HYDROCHLORIDE
Location	Trials
United States	28
Italy	14
China	8
Switzerland	2
Canada	2

Trials by US State

Trials by US State for BENAZEPRIL HYDROCHLORIDE
Location	Trials
New Jersey	5
North Carolina	4
North Dakota	3
West Virginia	2
California	2

Clinical Trial Progress for BENAZEPRIL HYDROCHLORIDE

Clinical Trial Phase

Clinical Trial Phase for BENAZEPRIL HYDROCHLORIDE
Clinical Trial Phase	Trials
Phase 4	14
Phase 3	7
Phase 2/Phase 3	1

Clinical Trial Status

Clinical Trial Status for BENAZEPRIL HYDROCHLORIDE
Clinical Trial Phase	Trials
Completed	33
Terminated	7
Active, not recruiting	1

Clinical Trial Sponsors for BENAZEPRIL HYDROCHLORIDE

Sponsor Name

Sponsor Name for BENAZEPRIL HYDROCHLORIDE
Sponsor	Trials
Novartis	6
Teva Pharmaceuticals USA	4
Dr. Reddy's Laboratories Limited	4

Sponsor Type

Sponsor Type for BENAZEPRIL HYDROCHLORIDE
Sponsor	Trials
Industry	28
Other	23